Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(30 sites)

China

Peking University First Hospital, Beijing, Beijing Municipality

Peking University People's Hospital, Beijing, Beijing Municipality

Peking University Third Hospital, Beijing, Beijing Municipality

The First Affiliated Hospital of Chongqing Medical University, Chongqing, Chongqing Municipality

Hebei University Affiliated Hospital, Baoding, Hebei